BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 20302564)

  • 1. Activation of sphingosine kinase-1 in cancer: implications for therapeutic targeting.
    Cuvillier O; Ader I; Bouquerel P; Brizuela L; Malavaud B; Mazerolles C; Rischmann P
    Curr Mol Pharmacol; 2010 Jun; 3(2):53-65. PubMed ID: 20302564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine kinase-1--a potential therapeutic target in cancer.
    Cuvillier O
    Anticancer Drugs; 2007 Feb; 18(2):105-10. PubMed ID: 17159597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sphingosine kinase 1 and tumor].
    Zhang CX; He HW; Shao RG
    Yao Xue Xue Bao; 2013 Jul; 48(7):971-8. PubMed ID: 24133963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death.
    Van Brocklyn JR; Williams JB
    Comp Biochem Physiol B Biochem Mol Biol; 2012 Sep; 163(1):26-36. PubMed ID: 22613819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy.
    Huwiler A; Pfeilschifter J
    Curr Pharm Des; 2006; 12(35):4625-35. PubMed ID: 17168766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease.
    Gangoiti P; Camacho L; Arana L; Ouro A; Granado MH; Brizuela L; Casas J; Fabriás G; Abad JL; Delgado A; Gómez-Muñoz A
    Prog Lipid Res; 2010 Oct; 49(4):316-34. PubMed ID: 20193711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
    Selvam SP; Ogretmen B
    Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy.
    Huwiler A; Zangemeister-Wittke U
    Crit Rev Oncol Hematol; 2007 Aug; 63(2):150-9. PubMed ID: 17560117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.
    Gault CR; Obeid LM
    Crit Rev Biochem Mol Biol; 2011 Aug; 46(4):342-51. PubMed ID: 21787121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulating sphingosine kinase-1 for cancer therapy.
    Cuvillier O
    Expert Opin Ther Targets; 2008 Aug; 12(8):1009-20. PubMed ID: 18620522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingolipids in macroautophagy.
    Lavieu G; Scarlatti F; Sala G; Carpentier S; Levade T; Ghidoni R; Botti J; Codogno P
    Methods Mol Biol; 2008; 445():159-73. PubMed ID: 18425450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis.
    Maceyka M; Payne SG; Milstien S; Spiegel S
    Biochim Biophys Acta; 2002 Dec; 1585(2-3):193-201. PubMed ID: 12531554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine kinase: biochemical and cellular regulation and role in disease.
    Taha TA; Hannun YA; Obeid LM
    J Biochem Mol Biol; 2006 Mar; 39(2):113-31. PubMed ID: 16584625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of sphingosine kinase/S1P axis in ECM remodeling of cardiac cells elicited by relaxin.
    Frati A; Ricci B; Pierucci F; Nistri S; Bani D; Meacci E
    Mol Endocrinol; 2015 Jan; 29(1):53-67. PubMed ID: 25415609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases.
    Hait NC; Oskeritzian CA; Paugh SW; Milstien S; Spiegel S
    Biochim Biophys Acta; 2006 Dec; 1758(12):2016-26. PubMed ID: 16996023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine kinase signalling in immune cells: potential as novel therapeutic targets.
    Melendez AJ
    Biochim Biophys Acta; 2008 Jan; 1784(1):66-75. PubMed ID: 17913601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.
    Tabuchi K; Hara A
    Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy.
    Zheng X; Li W; Ren L; Liu J; Pang X; Chen X; Kang D; Wang J; Du G
    Pharmacol Ther; 2019 Mar; 195():85-99. PubMed ID: 30347210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression.
    Dai L; Trillo-Tinoco J; Bai A; Chen Y; Bielawski J; Del Valle L; Smith CD; Ochoa AC; Qin Z; Parsons C
    Oncotarget; 2015 Sep; 6(27):24246-60. PubMed ID: 26327294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of sphingolipids metabolites in cellular proliferation modulated by ganglioside GM1.
    Wang F; Buckley NE; Olivera A; Goodemote KA; Su Y; Spiegel S
    Glycoconj J; 1996 Dec; 13(6):937-45. PubMed ID: 8981085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.